InvestorsHub Logo
Followers 17
Posts 343
Boards Moderated 0
Alias Born 07/01/2008

Re: kgromax post# 149202

Sunday, 02/28/2021 7:03:57 AM

Sunday, February 28, 2021 7:03:57 AM

Post# of 233047
KYGRO there are a few reasons the trial will fail. Among Them:

1. The SOC Standard of Care changed from the time they started.
Patients are now placed in prone position and predominantly provided HFNC which is high flow nasal canula.

But equally important is the steroids.

2. I think you will find many if not not most of the CYDY patients entered the trial before this new " SOC ".

3. FDA is looking at the data - and wants to take OUT the patients that were enrolled at a time PRIOR to this new SOC - on both arms.

4. So there are far too few patients.

Of course this is just my opinion

BUT what is NOT MY OPINION

5. CYDY DSMB Data Safety Monitoring Board SUGGESTED ANOTHER LOOK AT DATA for INFERIORITY - but apparently NADER said NO.

So their own DSMB is or was making recommendations that the CEO refused to follow.

But we all know how they blew the HIV BLA filing.......

So history here repeats ? ....


Anyway this is just my understanding at this time. DO not ask me ASK THE CEO write to him, call him, ask him.
Confirm the information I believe you will see it is 100% accurate but maybe I made a mistake.

I have sent he and his team questions, and received no reply.

Yes, I agree, this is an absolute failure you are correct.


. IS THERE ANY QUESTION WHY CYDY IS HIRING A PARALEGAL TO HELP SELL RESTRICTED SHARES ??? You bet your backside we know why.
.
.
. Good Luck to All ---

xxx.
xx.
x.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News